{"id":"8ec55d18-626b-4c73-a507-02e5bdc9f4e3","companyId":"4a8aba6d-bb8c-4522-a709-0db5a29fd16f","modelName":"Amazfit (Balance / Active / T-Rex / Helio)","slug":"amazfit","description":"Zepp Health Corporation (NYSE: ZEPP), the company formerly known as Huami and renamed in February 2021 under founder and chief executive Wang Huang, makes the Amazfit line of budget-tier biometric smartwatches, bands, and rings, recorded in the biometric form factor with the company as Zepp Health, the Amazfit consumer brand as the device line, and the Zepp app and its AI features as model attributes; its historical manufacturing of the Xiaomi Mi Band is an original-design-manufacturer note rather than a separate model line. The Amazfit line spans the Balance, Active, T-Rex, Bip, Cheetah, and Falcon devices plus the Helio Ring and Strap, pairing heart-rate, blood-oxygen, sleep, and stress sensing with genuine AI augmentation including the GPT-backed Zepp Flow voice assistant, the adaptive Zepp Coach, and the Zepp Aura AI sleep features. On FDA status, Amazfit devices are general-wellness and not FDA-cleared for medical features, with no FDA-cleared ECG app and atrial-fibrillation capability that is PPG-based rather than a cleared ECG path, and although a 2025 meta-analysis reported strong real-world atrial-fibrillation diagnostic accuracy for an Amazfit PPG system, that is published-study validation rather than FDA clearance, a distinction the registry keeps strictly separate. The company illustrates the scale-versus-validation framework, with high volume and real AI breadth but lighter clinical and regulatory validation than Apple or Withings: it reports more than 200 million devices shipped cumulatively to more than 53 million users across 150-plus countries and 2025 revenue of $258.9 million, up 41.8 percent year over year. Its claim to be the first to fully integrate AI into smartwatches is marketing rather than independently verified, its cumulative unit and user figures are company-reported, and its heart-health framing rides on PPG and a study rather than FDA clearance.","formFactor":"biometric","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"notes":[{"label":"Entity-scoping (resolved cleanly)","value":"Company / registry entity = ZEPP HEALTH CORPORATION (NYSE: ZEPP; public since 2018 as Huami/HMI; renamed Zepp Health Feb 2021; founder/CEO Wang Huang). Amazfit = the consumer hardware BRAND (Models attach here). Zepp = the app + AI layer (Zepp Flow/Coach/Aura) - model attributes, not separate entities. Historically made the Xiaomi Mi Band (ODM relationship) - a note, not a Zepp-branded model line."},{"label":"FDA status (the discipline anchor)","value":"Amazfit devices are GENERAL-WELLNESS, NOT FDA-cleared for medical features. No FDA-cleared ECG app; AFib-related capability is PPG-based, not a cleared ECG path. Nuance: a 2025 meta-analysis reported strong real-world AFib diagnostic accuracy for an Amazfit PPG system - but that is PUBLISHED-STUDY validation, NOT FDA clearance. Keep 'study-validated PPG' and 'FDA-cleared' strictly separate."},{"label":"Scale-vs-validation framework","value":"High volume + real AI breadth, lighter clinical/regulatory validation than Apple/Withings. Budget-tier at scale: >200M devices shipped cumulatively, >53M users, 150+ countries (company-reported). 2025 revenue $258.9M (+41.8% YoY; first growth since 2021). The budget-tier axis (vs Whoop/Oura premium, Apple/Samsung mainstream)."},{"label":"Cap-flag","value":"'First to fully integrate AI into smartwatches' is Amazfit MARKETING, not independently verified - do not assert. >200M units / 53M users are company-reported cumulative (aggregator-drift risk). AFib/heart-health framing rides on PPG + a study, not FDA clearance - tag as general-wellness. Per-year (vs cumulative) unit shipments not cleanly broken out."}],"specs":"Amazfit device line: Balance/Balance 2, Active/Active 2, T-Rex 3/Ultra, Bip 6, Cheetah, Falcon + Helio Ring/Strap. Sensors: HR, SpO2, sleep, stress (biometric-primary). AI: Zepp Flow (LLM voice assistant, GPT-backed), Zepp Coach (adaptive training/recovery), Zepp Aura (AI sleep). Entity: Company = Zepp Health Corp (NYSE: ZEPP, formerly Huami; founder Wang Huang); Amazfit = consumer brand; Zepp = app/AI layer; Mi Band = historical ODM note.","formFactor":"biometric (biometric-primary budget-tier smartwatch/band/ring + AI augmentation; general-wellness)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.zepp.com/press-release/huami-corporation-announces-name-change-to-zepp-health","title":"Huami -> Zepp Health rename (Feb 2021; ticker ZEPP); founder Wang Huang","sourceName":"Zepp Health (official)"},{"url":"https://us.amazfit.com/blogs/blog/amazfit-becomes-the-first-to-fully-integrate-ai-into-smartwatches","title":"Amazfit AI: Zepp Flow (GPT-backed assistant), Zepp Coach, Zepp Aura","sourceName":"Amazfit (official)"},{"url":"https://www.prnewswire.com/news-releases/zepp-health-corporation-reports-fourth-quarter-and-full-year-2025-unaudited-financial-results-302714084.html","title":"Zepp Health FY2025: revenue $258.9M +41.8% YoY; >200M devices, 53M users (company-reported)","sourceName":"Zepp Health (PR Newswire)"}],"aliases":["Amazfit Balance","Amazfit Active 2","Amazfit T-Rex 3","Amazfit Helio Ring"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-03T22:46:22.021Z","updatedAt":"2026-06-03T22:46:22.021Z","jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/amazfit","url":"https://registry.deploy.report/models/amazfit","name":"Amazfit (Balance / Active / T-Rex / Helio)","alternateName":["Amazfit Balance","Amazfit Active 2","Amazfit T-Rex 3","Amazfit Helio Ring"],"description":"Zepp Health Corporation (NYSE: ZEPP), the company formerly known as Huami and renamed in February 2021 under founder and chief executive Wang Huang, makes the Amazfit line of budget-tier biometric smartwatches, bands, and rings, recorded in the biometric form factor with the company as Zepp Health, the Amazfit consumer brand as the device line, and the Zepp app and its AI features as model attributes; its historical manufacturing of the Xiaomi Mi Band is an original-design-manufacturer note rather than a separate model line. The Amazfit line spans the Balance, Active, T-Rex, Bip, Cheetah, and Falcon devices plus the Helio Ring and Strap, pairing heart-rate, blood-oxygen, sleep, and stress sensing with genuine AI augmentation including the GPT-backed Zepp Flow voice assistant, the adaptive Zepp Coach, and the Zepp Aura AI sleep features. On FDA status, Amazfit devices are general-wellness and not FDA-cleared for medical features, with no FDA-cleared ECG app and atrial-fibrillation capability that is PPG-based rather than a cleared ECG path, and although a 2025 meta-analysis reported strong real-world atrial-fibrillation diagnostic accuracy for an Amazfit PPG system, that is published-study validation rather than FDA clearance, a distinction the registry keeps strictly separate. The company illustrates the scale-versus-validation framework, with high volume and real AI breadth but lighter clinical and regulatory validation than Apple or Withings: it reports more than 200 million devices shipped cumulatively to more than 53 million users across 150-plus countries and 2025 revenue of $258.9 million, up 41.8 percent year over year. Its claim to be the first to fully integrate AI into smartwatches is marketing rather than independently verified, its cumulative unit and user figures are company-reported, and its heart-health framing rides on PPG and a study rather than FDA clearance.","identifier":"8ec55d18-626b-4c73-a507-02e5bdc9f4e3","category":"biometric","publisher":{"@id":"https://deploy.report/#organization"}}}